These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2237832)

  • 1. Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients.
    Lindahl AK; Abildgaard U; Stokke G
    Thromb Res; 1990 Aug; 59(3):651-6. PubMed ID: 2237832
    [No Abstract]   [Full Text] [Related]  

  • 2. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood.
    Abildgaard U; Lindahl AK; Sandset PM
    Haemostasis; 1991; 21(4):254-7. PubMed ID: 1794751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrinsic coagulation pathway inhibitor during recombinant factor VIIa infusion.
    Sandset PM; Abildgaard U; Hedner U; Johansson H
    Thromb Haemost; 1989 Dec; 62(4):1146. PubMed ID: 2617462
    [No Abstract]   [Full Text] [Related]  

  • 5. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
    Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
    Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor.
    Lindahl AK; Abildgaard U; Staalesen R
    Thromb Res; 1991 Oct; 64(2):155-68. PubMed ID: 1811336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).
    Sandset PM; Abildgaard U; Larsen ML
    Thromb Res; 1988 Jun; 50(6):803-13. PubMed ID: 3413731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Curr Stud Hematol Blood Transfus; 1991; (58):22-5. PubMed ID: 1954769
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
    Warn-Cramer BJ; Almus FE; Rapaport SI
    Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation.
    Lindahl AK; Abildgaard U; Larsen ML; Aamodt LM; Nordfang O; Beck TC
    Thromb Res Suppl; 1991; 14():39-48. PubMed ID: 1658969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor.
    Novotny WF; Palmier M; Wun TC; Broze GJ; Miletich JP
    Blood; 1991 Jul; 78(2):394-400. PubMed ID: 2070077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.
    Bajaj MS; Kuppuswamy MN; Saito H; Spitzer SG; Bajaj SP
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8869-73. PubMed ID: 2247459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
    Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
    Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tissue factor and inhibitor of the blood coagulation pathway in nephrotic syndrome].
    Małyszko JS; Małyszko J; Myśliwiec M
    Pol Arch Med Wewn; 1999 Apr; 101(4):301-5. PubMed ID: 10740407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood coagulation and fibrinolysis: an overview.
    Mosher DF
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI5-11. PubMed ID: 2191814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy.
    Sandset PM; Hellgren M; Uvebrandt M; Bergström H
    Thromb Res; 1989 Sep; 55(5):665-70. PubMed ID: 2814949
    [No Abstract]   [Full Text] [Related]  

  • 17. Extrinsic pathway inhibitor in elective surgery: a comparison with other coagulation inhibitors.
    Sandset PM; Høgevold HE; Lyberg T; Andersson TR; Abildgaard U
    Thromb Haemost; 1989 Nov; 62(3):856-60. PubMed ID: 2595660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor pathway inhibitor revisited.
    Hjort PF; Sandset PM; Abildgaard U; Rao LV; Mast A; Ott I; Bajaj SP
    J Thromb Haemost; 2004 Dec; 2(12):2241-9. PubMed ID: 15613032
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergism between full length TFPI and heparin: evidence for TFPI as an important factor for the antithrombotic activity of heparin.
    Valentin S; Ostergaard P; Kristensen H; Nordfang O
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):221-2. PubMed ID: 1318759
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced inhibition of tissue factor by the extended form of an endothelial cell glycoprotein (an extrinsic pathway inhibitor).
    Colburn P; Crabb JW; Buonassisi V
    J Cell Physiol; 1991 Aug; 148(2):320-6. PubMed ID: 1880157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.